Early detection of oral premalignant lesions (OPMLs) by visual inspection with toluidine blue has not been addressed. We conducted a community-based randomized controlled trial to assess whether using toluidine blue as an adjunctive tool for visual screening had a higher detection rate of OPMLs and could further reduce the incidence of oral cancer. In 2000, in Keelung, we randomly assigned a total of 7975 individuals, aged 15 years or older and with high-risk oral habits, to either the toluidine-blue-screened (TBS) group or the visual screening group. Results showed 5% more oral premalignant lesions and 79% more oral submucous fibrosis detected in the TBS group than in the control group. After a five-year follow-up ascertaining oral cancer development through linkage to the National Cancer Registry, the incidence rate in the TBS group (28.0 x 10−5) was non-significantly 21% lower than that in the control group (35.4 x 10−5).
KramerIRLucasRBPindborgJJSobinLH (1978). Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol46:518-539.
4.
LeeCHKoYCHuangHLChaoYYTsaiCCShiehTY. (2003). The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer88:366-372.
5.
Lullmann-RauchR (1989). Experimental mucopolysaccharidosis: preservation and ultrastructural visualization of intralysosomal glycosaminoglycans by use of the cationic dyes cuprolinic blue and toluidine blue. Histochemistry93:149-154.
6.
MartinICKerawalaCJReedM (1998). The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod85:444-446.
7.
MashbergA (1980). Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III. Cancer46:758-763.
8.
MashbergA (1981). Tolonium (toluidine blue) rinse—a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV. J Am Med Assoc245:2408-2410.
9.
MashbergA (1984). Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol57:379-382.
10.
MathewBSankaranarayananRSunilkumarKBKuruvilaBPisaniPNairMK (1997). Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer76:390-394.
11.
PandeyMThomasGSomanathanTSankaranarayananRAbrahamEKJacobBJ. (2001). Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol37:103-109.
12.
PattonLL (2003). The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol39:708-723.
13.
ProutMNSidariJNWitzburgRAGrilloneGAVaughanCW (1997). Head and neck cancer screening among 4611 tobacco users older than forty years. Otolaryngol Head Neck Surg116:201-208.
14.
RamadasKSankaranarayananRJacobBJThomasGSomanathanTMaheC. (2003). Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol39:580-588.
15.
RosenbergDCretinS (1989). Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol67:621-627.
16.
SankaranarayananRMathewBJacobBJThomasGSomanathanTPisaniP. (2000). Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer88:664-673.
17.
SankaranarayananRRamadasKThomasGMuwongeRTharaSMathewB. (2005). Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet365:1927-1933.
18.
ShiuMNChenTH (2003). Intervention efficacy and malignant transformation to oral cancer among patients with leukoplakia (review). Oncol Rep10:1683-1692.
19.
ShiuMNChenTH (2004). Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev13:39-45.
20.
ShiuMNChenTHChangSHHahnLJ (2000). Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer82:1871-1874.
21.
SilvermanSJrMiglioratiC (1992). Toluidine blue staining and early detection of oral precancerous and malignant lesions. Iowa Dent J78:15-16.
22.
SilvermanSJrMiglioratiCBarbosaJ (1984). Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol57:379-382.
23.
WarnakulasuriyaKAJohnsonNW (1996). Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med25:97-103.
24.
YangYHChenCHChangJSLinCCChengTCShiehTY (2005). Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J Oral Pathol Med34:596-601.
25.
YenAMChenSCChenTH (2007). Dose-response relationships of oral habits associated with the risk of oral pre-malignant lesions among men who chew betel quid. Oral Oncol43:634-638.
